Fire-district
Brilliant Fire Department
Brilliant Fire Department (Brilliant, OH) carries 34 drugs across 136 dose entries in its current published protocol, effective 2025-03-10.
Drugs and doses34
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 40 mg | PO | not captured | standing | page 5 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 6 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 6 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | NEB | not captured | standing | page 7 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 7 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 7 |
Albuterol-Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 3 mL | NEB | not captured | standing | page 18 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | not captured | not captured | standing | page 9 |
| Other | adult | 150 mg | not captured | not captured | standing | page 9 |
| Other | adult | 300 mg | IV | not captured | standing | page 9 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 9 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 9 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 325 mg | PO | not captured | standing | page 10 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1–2 mg | IV | not captured | standing | pages 11, 12 |
| Other | adult | 0.5 mg | IV | not captured | standing | pages 11, 12 |
| Other | adult | 0.5 mg | IV | not captured | standing | pages 11, 12 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | pages 11, 12 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mL | IV | not captured | standing | page 13 |
| Other | adult | 10 mL | IV | not captured | standing | page 13 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 15 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | page 15 |
| Other | adult | 25 g | IV/IO | not captured | standing | page 15 |
| Other | adult | 25 g | IV/IO | not captured | standing | page 15 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | page 15 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | page 15 |
| Status epilepticus | adult | 25 g | IV/IO | not captured | standing | page 15 |
| Status epilepticus | peds | 2 mL/kg | IV/IO | not captured | standing | page 15 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IM | not captured | standing | page 16 |
| Agitation | peds | 0.5–2 mg | IM | not captured | standing | page 16 |
| Procedural sedation | adult | 5 mg | IV | not captured | standing | page 16 |
| Status epilepticus | adult | 2–5 mg | IM | not captured | standing | page 16 |
| Status epilepticus | adult | 5 mg | IV | not captured | standing | page 16 |
| Status epilepticus | peds | 0.5–2 mg | IV | not captured | standing | page 16 |
| Status epilepticus | peds | 0.5–2 mg | IM | not captured | standing | page 16 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 14 |
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | page 14 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25 mg | IV | not captured | standing | page 17 |
| Anaphylaxis | adult | 25–50 mg | IM | not captured | standing | page 17 |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | page 17 |
| Anaphylaxis | adult | 50 mg | IV | not captured | standing | page 17 |
| Anaphylaxis | peds | 1 mg/kg | IM | not captured | standing | page 17 |
| Anaphylaxis | peds | 1 mg/kg | IV | not captured | standing | page 17 |
| Anaphylaxis | peds | 1 mg/kg | IM | not captured | standing | page 17 |
| Anaphylaxis | peds | 1 mg/kg | IV | not captured | standing | page 17 |
| Dystonic reaction | adult | 25 mg | IV | not captured | standing | page 17 |
| Dystonic reaction | adult | 50 mg | IM | not captured | standing | page 17 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 20 |
| Anaphylaxis | adult | 0.3–0.5 mg | IV | not captured | standing | page 20 |
| Asthma / bronchospasm | adult | 0.3–0.5 mL | IM | not captured | standing | page 20 |
| Bradycardia | peds | 0.01 mg/kg | IV | not captured | standing | page 20 |
| Cardiac arrest | adult | 1 mg | IV | not captured | standing | page 20 |
| Cardiac arrest | adult | 2 mg | ET | not captured | standing | page 20 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV | not captured | standing | page 21 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 25–100 mcg | IV/IM/IN | not captured | standing | page 22 |
| Severe pain | peds | 0.5–1 mcg/kg | IV/IM/IN | not captured | standing | page 22 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40–80 mg | IV | not captured | standing | page 23 |
| CHF / pulmonary edema | adult | 40–80 mg | IV | not captured | standing | page 23 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 23 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 23 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg | IV/IM/IN | not captured | standing | page 24 |
| Anaphylaxis | peds | 0.5 mg | IV/IM/IN | not captured | standing | page 24 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 24 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | page 24 |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | page 24 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IV/IM/IN | not captured | standing | page 25 |
| Hyperactive delirium | adult | 4 mg/kg | IV/IM/IN | not captured | standing | page 25 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 25 |
| Severe pain | adult | See Pain Management Protocol | IV/IO | not captured | standing | page 25 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15–30 mg | IV/IO | not captured | standing | page 43 |
| Mild to moderate pain | adult | 30–60 mg | IM | not captured | standing | page 43 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV | not captured | standing | page 26 |
| Other | peds | 25–50 mL | IO | not captured | standing | page 26 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV | not captured | standing | page 26 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO/ET | not captured | standing | page 26 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO/ET | not captured | standing | page 26 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | not captured | not captured | standing | page 28 |
| Asthma / bronchospasm | peds | 25 mg/kg | not captured | not captured | standing | page 28 |
| Eclampsia / pre-eclampsia | adult | 4 g | not captured | not captured | standing | page 28 |
| Other | adult | 1–2 g | IV | not captured | standing | page 28 |
| VF / pulseless VT | adult | 1–2 g | IV | not captured | standing | page 28 |
| VF / pulseless VT | adult | 1–2 g | IV | not captured | standing | page 28 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV | not captured | standing | page 28 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125–250 mg | IV/IO | not captured | standing | page 29 |
| Allergic reaction | peds | 2 mg/kg | IV/IO | not captured | standing | page 29 |
| Anaphylaxis | adult | 125–250 mg | IV/IO | not captured | standing | page 29 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 29 |
| Asthma / bronchospasm | adult | 125–250 mg | IV/IO | not captured | standing | page 29 |
| Asthma / bronchospasm | adult | 125–250 mg | IV/IO | not captured | standing | page 29 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO | not captured | standing | page 29 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO | not captured | standing | page 29 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5 mg | IV/IO | not captured | standing | page 27 |
| Atrial fibrillation with RVR | adult | 5 mg | IV/IO | not captured | standing | page 27 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 27 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 27 |
| SVT | adult | 5 mg | IV/IO | not captured | standing | page 27 |
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | page 27 |
| VF / pulseless VT | adult | 5 mg | IV/IO | not captured | standing | page 27 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV | not captured | standing | page 30 |
| Agitation | adult | 2–5 mg | IM/IN | not captured | standing | page 30 |
| Hyperactive delirium | adult | 5 mg | IV/IM/IN | not captured | standing | page 31 |
| Other | adult | 1–2 mg | IV | not captured | standing | page 30 |
| Other | adult | 2–4 mg | IV | not captured | standing | pages 30, 31 |
| Other | adult | 4 mg | IN | not captured | standing | page 30 |
| Other | peds | 0.2 mg/kg | IV | not captured | standing | pages 30, 31 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 30, 31 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | pages 30, 31 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 30, 31 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 30, 31 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2–5 mg | IV | not captured | standing | page 32 |
| CHF / pulmonary edema | adult | 2–5 mg | IV | not captured | standing | page 32 |
| Mild to moderate pain | adult | 2–5 mg | IV | not captured | standing | page 32 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV | not captured | standing | page 32 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IV | not captured | standing | pages 34, 35 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | pages 33, 34, 35 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 33, 34, 35 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 36 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 36 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 36 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 45 |
| Nausea / vomiting | adult | 4 mg | IM | not captured | standing | page 45 |
| Nausea / vomiting | adult | 4–8 mg | SL | not captured | standing | page 45 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | page 45 |
| Nausea / vomiting | peds | 0.5 tablet | SL | not captured | standing | page 45 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | not captured | not captured | standing | page 8 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | peds | 0.5 mL | NEB | not captured | standing | page 38 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV | not captured | standing | page 39 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV | not captured | standing | page 41 |
| Cardiac arrest | peds | 1 mEq/kg | IV | not captured | standing | page 41 |
| Hyperkalemia | adult | 50 mEq | IV | not captured | standing | page 41 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 41 |
| Other | adult | 50 mEq | IV | not captured | standing | page 41 |
| Other | peds | 0.5 mEq/kg | IV | not captured | standing | page 41 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | not captured | not captured | standing | page 42 |
| Other | peds | 1–2 drop | not captured | not captured | standing | page 42 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV | not captured | standing | page 44 |
| Other | peds | 15 mg/kg | IV | not captured | standing | page 44 |